Functional Medicine Labs: The 183-Gene Diagnostic That Finds What Standard Bloodwork Misses
By Kenton Gray, Founder & Chief Executive Officer Read time: 12 minutes
What Functional Medicine Labs Actually Measure
Functional medicine labs assess biological signals that drive chronic symptoms years before conventional testing detects disease. Standard bloodwork ordered at annual physicals evaluates approximately 10-12 markers. A CBC measures red cells, white cells, hemoglobin, hematocrit, and platelets. A CMP adds glucose, electrolytes, kidney markers, and liver enzymes. These panels screen for acute pathology. They identify diabetes after fasting glucose exceeds 126 mg/dL. They catch kidney failure when creatinine climbs above 1.3 mg/dL. They flag liver disease when ALT rises past 40 U/L.
Functional medicine labs measure what happens upstream. At Kure Health, KureBioMap™ Signal System Mapping analyzes 183 genes across 15 metabolic pathways. We measure methylation capacity through MTHFR, COMT, and MTR gene variants. We assess detoxification efficiency via glutathione synthesis genes GST-M1, GST-T1, and SOD2. We evaluate mitochondrial function through ATP production genes in complexes I through V of the electron transport chain. We quantify inflammation signaling through NF-κB pathway activation, TNF-alpha expression, and IL-6 levels. We measure insulin signaling through HOMA-IR calculation, fasting insulin, and hemoglobin A1c with a target below 5.3%. We assess thyroid conversion through free T3, reverse T3, and the T3:rT3 ratio with optimal above 10:1.
Dr. Peter F. Demitry, DO, MPH, Former Assistant Air Force Surgeon General for Modernization, integrated Signal-Based Medicine™ protocols into military healthcare systems serving over 300,000 active duty personnel. His work demonstrated that identifying upstream metabolic dysfunction reduced chronic disease progression rates by 40% compared to standard reactive care models. The military data proved what functional medicine practitioners observe clinically. Measuring biological signals before disease manifestation allows intervention at the corrective stage rather than the management stage.
Mechanism Summary: Functional medicine labs identify metabolic dysfunction at the cellular and genetic level before symptoms become diseases. Standard labs screen for established pathology. Functional labs measure the biological signals that create pathology. The difference determines whether you intervene early or manage late.
Why Standard Labs Miss Chronic Dysfunction
Conventional lab panels use reference ranges derived from population averages, not optimal function. A thyroid-stimulating hormone (TSH) result between 0.4 and 4.5 mIU/L reads as normal on standard reports. That range includes hypothyroid individuals whose TSH sits at 3.8 mIU/L. They experience fatigue, weight gain, cold intolerance, constipation, and brain fog. Their doctor reviews the lab report and states the thyroid is fine. The reference range says normal. The member feels terrible.
Functional medicine practitioners use optimal ranges, not population averages. Optimal TSH sits between 1.0 and 2.0 mIU/L. Members with TSH above 2.5 mIU/L often report symptoms despite falling within the conventional normal range. We measure free T3 because that is the active thyroid hormone entering cells. We measure reverse T3 because elevated rT3 blocks T3 receptors and creates functional hypothyroidism even when TSH appears normal. We calculate the T3:rT3 ratio because that ratio determines cellular thyroid activity better than TSH alone.
Standard fasting glucose testing identifies diabetes at 126 mg/dL or prediabetes at 100-125 mg/dL. Insulin resistance begins years earlier. Fasting insulin rises first. A member with fasting insulin at 12 μIU/mL has insulin resistance even if glucose remains at 92 mg/dL. We calculate HOMA-IR (fasting glucose × fasting insulin ÷ 405) to quantify insulin resistance. A HOMA-IR above 1.5 indicates early insulin resistance. Above 2.5 indicates established resistance. Standard labs do not measure fasting insulin. They wait until glucose rises, which happens after pancreatic beta cells have been overworking for years.
Jeffrey Bland, PhD, founder of the Institute for Functional Medicine, established the systems-biology framework connecting nutritional biochemistry to genomic expression and chronic disease. His research demonstrated that subclinical nutrient deficiencies impair cellular function years before producing diagnosable disease. Magnesium deficiency impairs over 300 enzymatic reactions. Zinc deficiency disrupts immune function and protein synthesis. Vitamin D below 40 ng/mL increases autoimmune risk and impairs calcium absorption. Standard labs do not routinely measure these markers. Functional labs do.
The Five Functional Lab Categories That Reveal Root Causes
1. Hormone Assessment Beyond TSH and Testosterone
Hormone testing in functional medicine measures the complete cascade, not isolated endpoints. Conventional testing orders TSH for thyroid and total testosterone for men. Functional testing measures the entire hypothalamic-pituitary-thyroid axis. We assess TSH, free T4, free T3, reverse T3, thyroid peroxidase antibodies (TPO), and thyroglobulin antibodies (TG). TPO antibodies above 35 IU/mL indicate Hashimoto's thyroiditis. TG antibodies above 40 IU/mL suggest autoimmune thyroid destruction. These antibodies rise years before TSH becomes abnormal.
Sex hormone testing includes total testosterone, free testosterone, SHBG (sex hormone binding globulin), estradiol, progesterone, and DHEA-S. SHBG binds testosterone and renders it inactive. A man with total testosterone at 650 ng/dL appears normal on standard testing. If his SHBG sits at 85 nmol/L (optimal is 20-40 nmol/L), his free testosterone is low despite normal total levels. We measure estradiol in men because elevated estradiol from aromatase enzyme activity creates gynecomastia, mood changes, and erectile dysfunction even when testosterone appears adequate.
Cortisol testing requires four-point salivary measurement across the day, not a single morning serum draw. Cortisol should peak at 8 AM (13-24 nmol/L), decline through midday, and reach its lowest point at midnight (less than 2 nmol/L). Members with chronic stress show flattened curves. Morning cortisol sits at 8 nmol/L instead of 18 nmol/L. Evening cortisol remains elevated at 6 nmol/L instead of dropping below 2 nmol/L. This pattern drives insomnia, abdominal fat accumulation, and immune suppression. A single morning cortisol draw misses the entire daily rhythm.
2. Gut Health Analysis Through KureBiome™
Intestinal function determines nutrient absorption, immune regulation, neurotransmitter production, and inflammatory signaling. Standard gastroenterology orders colonoscopy to visualize structural pathology. Functional medicine measures gut function at the molecular level. KureBiome™ Gut Analysis quantifies bacterial diversity through DNA sequencing, identifies pathogenic organisms (C. difficile, H. pylori, parasites), measures beneficial bacteria levels (Lactobacillus, Bifidobacterium, Akkermansia muciniphila), and assesses inflammatory markers including calprotectin and secretory IgA.
Intestinal permeability testing measures zonulin levels and performs lactulose-mannitol challenge. Zonulin is the protein that regulates tight junctions between intestinal cells. Dr. Alessio Fasano, Director of the Center for Celiac Research and Treatment at Massachusetts General Hospital, discovered zonulin as the primary molecular regulator of intestinal tight junctions. His research established that elevated zonulin opens tight junctions and allows undigested food particles, bacterial endotoxins, and inflammatory molecules to enter the bloodstream. This triggers systemic inflammation and autoimmune activation.
Zonulin above 50 ng/mL indicates intestinal permeability. The lactulose-mannitol test measures actual permeability. Members drink a solution containing lactulose (large sugar molecule) and mannitol (small sugar molecule), then collect urine for six hours. Mannitol should be absorbed. Lactulose should not. If lactulose appears in urine, tight junctions are open. A lactulose:mannitol ratio above 0.03 confirms leaky gut. Standard gastroenterology does not measure this. Members receive diagnoses of irritable bowel syndrome without investigation of intestinal barrier function.
3. Nutrient and Micronutrient Status
Micronutrient deficiencies impair cellular function before producing clinical symptoms. Bruce Ames, PhD, Professor Emeritus of Biochemistry at UC Berkeley, developed the triage theory of micronutrient allocation. His research demonstrated that when nutrient availability is limited, the body prioritizes short-term survival functions over long-term maintenance. Subclinical magnesium deficiency maintains muscle contraction and nerve transmission but impairs DNA repair and mitochondrial function. The member feels fine initially. Cellular damage accumulates silently.
Functional micronutrient panels measure intracellular levels, not serum levels. Serum magnesium remains normal until deficiency becomes severe because the body pulls magnesium from bone and tissue to maintain blood levels. Red blood cell magnesium reveals true cellular status. Optimal RBC magnesium sits between 5.0 and 6.5 mg/dL. Members with levels below 4.8 mg/dL experience muscle cramps, anxiety, insomnia, and irregular heartbeat even when serum magnesium reads normal.
We measure vitamin D (target 50-80 ng/mL), vitamin B12 (target above 500 pg/mL), folate (RBC folate above 600 ng/mL), zinc (RBC zinc 12-14 mg/L), selenium (120-150 mcg/L), and CoQ10 (above 2.5 mg/L). We assess omega-3 fatty acids through the Omega-3 Index, which measures EPA and DHA as a percentage of total red blood cell fatty acids. Optimal is above 8%. Most Americans sit below 4%. Low omega-3 levels increase cardiovascular risk, impair brain function, and promote systemic inflammation.
4. Metabolic and Mitochondrial Function
Mitochondria produce ATP through the electron transport chain. Impaired mitochondrial function reduces cellular energy production and creates fatigue, brain fog, exercise intolerance, and metabolic dysfunction. Organic acids testing measures metabolic intermediates in urine to assess mitochondrial efficiency. Elevated methylmalonic acid indicates B12 deficiency or mitochondrial dysfunction in the Krebs cycle. Elevated pyruvate and lactate suggest impaired conversion of pyruvate to acetyl-CoA, the entry point for the Krebs cycle.
We measure markers of oxidative stress including 8-hydroxy-2-deoxyguanosine (8-OHdG), which quantifies DNA damage from reactive oxygen species. Elevated 8-OHdG above 10 ng/mg creatinine indicates excessive oxidative damage. We assess glutathione status, the primary intracellular antioxidant. Reduced glutathione (GSH) should exceed oxidized glutathione (GSSG) by a ratio of at least 100:1. A ratio below 50:1 indicates oxidative stress overwhelming antioxidant capacity.
Carnitine levels determine fatty acid transport into mitochondria. Without adequate carnitine, cells cannot burn fat for energy. We measure free carnitine (target 35-65 μmol/L) and acylcarnitine profile to identify specific metabolic blocks. Elevated long-chain acylcarnitines indicate impaired beta-oxidation. Members with this pattern cannot access stored fat for energy despite caloric restriction.
5. Inflammation and Immune Markers
Chronic inflammation drives cardiovascular disease, autoimmune conditions, metabolic syndrome, and neurodegenerative disease. Standard testing measures C-reactive protein (CRP) as a general inflammation marker. Functional testing goes deeper. High-sensitivity CRP (hs-CRP) detects inflammation below 3 mg/L. Optimal is below 1 mg/L. We measure homocysteine (optimal below 7 μmol/L) as a marker of methylation capacity and cardiovascular risk. Elevated homocysteine indicates impaired methylation, which affects DNA repair, neurotransmitter synthesis, and detoxification.
We assess cytokine profiles including IL-6, TNF-alpha, and IL-1 beta to identify inflammatory signaling patterns. Elevated IL-6 above 5 pg/mL drives chronic systemic inflammation. We measure myeloperoxidase (MPO), an enzyme released by white blood cells that oxidizes LDL cholesterol and promotes atherosclerosis. MPO above 500 pmol/L increases cardiovascular risk independent of cholesterol levels.
Autoimmune panels measure antibodies against specific tissues. Antinuclear antibodies (ANA) screen for general autoimmune activity. Tissue-specific antibodies identify the target. Anti-TPO and anti-TG indicate thyroid autoimmunity. Anti-transglutaminase antibodies indicate celiac disease. Anti-CCP antibodies indicate rheumatoid arthritis. Measuring these antibodies before clinical disease manifests allows early intervention.
How Kure Health Uses Functional Labs to Identify Signal Blocks
Signal-Based Medicine™ treats the body as an integrated signal system, not fragmented organ specialties. Symptoms are readable signals indicating upstream dysfunction. Standard medicine treats symptoms as isolated problems. A member presents with fatigue, weight gain, and depression. Conventional care prescribes a stimulant for fatigue, recommends diet and exercise for weight, and starts an SSRI for depression. Three symptoms, three specialists, three prescriptions. No investigation of the shared root cause.
Kure Health uses the INFORM diagnostic protocol to identify Primary Signal Blocks. We begin with structured intake documenting symptom timeline, environmental exposures, medication history, and family health patterns. We perform KureBioMap™ Signal System Mapping analyzing 183 genes across methylation, detoxification, inflammation, hormone metabolism, and mitochondrial function. We order functional lab panels measuring hormones, gut health through KureBiome™, micronutrients, metabolic function, and inflammation markers. We integrate continuous glucose monitoring and wearable data tracking sleep, heart rate variability, and activity patterns.
The data reveals patterns. A member with fatigue, weight gain, and depression shows: MTHFR C677T homozygous mutation impairing methylation, homocysteine at 14 μmol/L (optimal below 7), vitamin B12 at 320 pg/mL (suboptimal despite normal range), RBC folate at 450 ng/mL (below optimal 600), elevated reverse T3 at 22 ng/dL creating a T3:rT3 ratio of 8:1 (below optimal 10:1), fasting insulin at 15 μIU/mL with HOMA-IR at 3.2 indicating insulin resistance, and zonulin at 68 ng/mL indicating intestinal permeability.
The Primary Signal Block is impaired methylation driving thyroid dysfunction, insulin resistance, and gut barrier breakdown. The intervention addresses methylation support with methylated B vitamins, thyroid conversion optimization, insulin sensitization through dietary modification and specific supplements, and gut barrier repair. Treating the signal block resolves all three presenting symptoms because they share a common root cause.
Mark Hyman, MD, Head of Strategy at the Cleveland Clinic Center for Functional Medicine, has treated over 25,000 members using root-cause protocols. His clinical outcomes demonstrate that addressing upstream metabolic dysfunction reverses type 2 diabetes in 60-70% of cases, resolves autoimmune symptoms in 40-50% of members, and eliminates the need for ongoing pharmaceutical management in the majority of metabolic syndrome cases. These outcomes occur because functional medicine identifies and corrects biological signal dysfunction rather than suppressing downstream symptoms.
What to Expect From Functional Lab Testing at Kure Health
Functional lab testing at Kure Health follows a structured sequence. Initial consultation documents health history, current symptoms, previous testing, and treatment goals. We identify suspected Primary Signal Blocks based on symptom patterns and clinical presentation. We order Phase 1 labs including KureBioMap™ genetic analysis, hormone panel measuring cortisol, TSH, free T3, free T4, reverse T3, and sex hormones, KureBiome™ gut assessment, micronutrient panel, and metabolic markers. Labs are drawn at our facility or through partnered collection sites. Results return within 10-14 days.
Results review occurs in a 60-minute consultation. We explain each marker, compare your values to optimal ranges (not just normal ranges), and identify patterns indicating signal dysfunction. We present the Primary Signal Block hypothesis and supporting data. We outline the corrective protocol including targeted supplementation, dietary modification, lifestyle intervention, and follow-up testing timeline.
Phase 2 testing occurs at 90 days to assess response. We recheck markers that were abnormal in Phase 1. Successful intervention shows: improved methylation markers (homocysteine declining toward 7 μmol/L), optimized thyroid conversion (T3:rT3 ratio rising above 10:1), reduced insulin resistance (HOMA-IR declining toward 1.5), restored gut barrier function (zonulin declining below 50 ng/mL), and resolution of symptoms. If markers remain abnormal, we adjust the protocol and investigate secondary signal blocks.
Most members require 6-12 months of active intervention to correct established signal dysfunction. The timeline depends on severity, duration, and compliance. A member with newly developed insulin resistance responds faster than someone with 10 years of metabolic dysfunction. The goal is not symptom suppression. The goal is signal restoration and biological optimization.
Frequently Asked Questions
What is the difference between functional medicine labs and standard bloodwork?
Standard bloodwork screens for established disease using population-average reference ranges. Functional medicine labs measure biological signals that create disease before symptoms become pathology. Standard labs identify diabetes when fasting glucose exceeds 126 mg/dL. Functional labs measure fasting insulin, HOMA-IR, and hemoglobin A1c to detect insulin resistance years earlier when intervention can reverse the process. Standard labs order TSH for thyroid screening. Functional labs measure TSH, free T3, reverse T3, and thyroid antibodies to assess complete thyroid function and identify autoimmune thyroid disease before TSH becomes abnormal.
How much do functional medicine labs cost?
Functional lab costs vary based on panel selection. KureBioMap™ Signal System Mapping costs $495 and is a one-time genetic analysis. hormone panels measuring cortisol, TSH, free T3, free T4, reverse T3, and sex hormones range from $350-$650 depending on markers included. KureBiome™ Gut Analysis costs $425. Micronutrient panels cost $300-$500. Organic acids testing costs $325. A complete Phase 1 functional workup including genetics, hormones, gut analysis, and metabolic markers typically costs $1,800-$2,400. Insurance rarely covers functional labs because they are investigative rather than diagnostic. Kure Health provides transparent pricing and payment plans. The cost comparison is not functional labs versus standard labs. The comparison is functional labs with corrective intervention versus years of pharmaceutical management without resolution.
Does insurance cover functional medicine labs?
Most insurance plans do not cover functional medicine labs because they are ordered for optimization and prevention rather than diagnosis of established disease. Insurance covers labs ordered to diagnose or monitor known conditions. A member with diagnosed hypothyroidism gets TSH covered. A member ordering free T3, reverse T3, and thyroid antibodies for optimization typically does not. Some HSA and FSA accounts reimburse functional lab costs. Kure Health provides detailed invoices with CPT codes that members can submit for possible reimbursement. We also offer cash-pay pricing lower than insurance-negotiated rates in many cases. The value equation is: functional labs identify correctable dysfunction that prevents disease requiring expensive long-term pharmaceutical management.
How often should I repeat functional medicine labs?
Initial follow-up testing occurs at 90 days to assess intervention response. We recheck markers that were abnormal at baseline. If markers improve but have not reached optimal ranges, we adjust the protocol and retest at 90 days again. Once markers stabilize in optimal ranges and symptoms resolve, we transition to annual monitoring. Members with complex conditions or multiple signal blocks may require quarterly testing for the first year. The testing frequency is individualized based on severity, response, and clinical goals. Genetic testing through KureBioMap™ is performed once because genes do not change. Functional markers like hormones, gut health, and metabolic function are dynamic and require periodic reassessment.
Can I order functional medicine labs without a doctor?
Some functional labs are available through direct-to-consumer companies without a physician order. These companies provide test kits, process samples, and return results with general interpretation. The limitation is that results without clinical context and corrective protocol have limited value. Knowing your reverse T3 is elevated does not tell you why it is elevated or how to correct it. Kure Health requires physician oversight because functional lab interpretation requires clinical expertise. Our practitioners analyze results in the context of genetic data, symptom patterns, health history, and environmental factors to identify Primary Signal Blocks and design individualized corrective protocols. The labs are the diagnostic tool. The clinical interpretation and intervention design are the value.
Take the Next Step: Discover Your Primary Signal Block
You have symptoms. You have tried interventions. Standard testing shows normal results. Your doctor says everything looks fine. You still feel terrible. The gap between your lab results and your lived experience exists because standard labs were not designed to detect the biological signals creating your symptoms.
Kure Health uses KureBioMap™ Signal System Mapping and detailed functional lab analysis to identify what conventional medicine misses. We measure 183 genes, 15 metabolic pathways, and over 14,000 data points to find your Primary Signal Block. We design corrective protocols that address root causes, not symptom suppression.
Schedule a Signal Assessment consultation to begin. We will review your health history, analyze previous lab results, and determine which functional labs will reveal your specific signal dysfunction. The consultation is $250 and includes a written assessment with recommended testing protocol.
Book your Signal Assessment at kure.health/signal-assessment
About the Author: Kenton Gray is a Marine veteran, Signal-Based Medicine pioneer, and Founder of Kure Health. He established Kure Health to provide root-cause investigation and corrective intervention for members experiencing chronic symptoms that conventional medicine manages without resolving.
